Patient
SITE011-0049
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2025-11-05
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-03-11 (study day 309); relationship: not assessed
Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-01-13 (study day 252); relationship: RELATED
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-12-27 (study day 235); relationship: not assessed
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-07-03 (study day 58); relationship: NOT RELATED
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-05-30 (study day 24); relationship: NOT RELATED
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-05-11 (study day 5); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.